Multidimensional Sleep Health, Glycemic Control, and Self-reported Outcomes in Type 1 Diabetes: A Cross-sectional Study

被引：0

作者：

Abu Irsheed, Ghada ^{[1
]}

Steffen, Alana ^{[2
]}

Martyn-Nemeth, Pamela ^{[1
]}

Park, Minsun ^{[1
]}

Quinn, Laurie ^{[1
]}

Duffecy, Jennifer ^{[3
]}

Baron, Kelly Glazer ^{[4
]}

Saleh, Adam Hussain ^{[1
]}

Takgbajouah, Mary ^{[1
,5
]}

Bimbi, Olivia ^{[1
]}

Kessler, Justine ^{[1
]}

Mihailescu, Dan ^{[6
]}

Reutrakul, Sirimon ^{[1
,7
]}

机构：

[1] Univ Illinois, Coll Nursing, Dept Biobehav Nursing Sci, 845 S Damen Ave MC 802, Chicago, IL 60612 USA

[2] Univ Illinois, Coll Nursing, Dept Populat Hlth Nursing Sci, Chicago, IL 60612 USA

[3] Univ Illinois, Coll Med, Dept Psychiat, Chicago, IL 60612 USA

[4] Univ Utah, Dept Family & Prevent Med, Div Publ Hlth, Salt Lake City, UT 84108 USA

[5] DePaul Univ, Dept Psychol, Chicago, IL 60614 USA

[6] Cook Cty Hlth, Div Endocrinol, Chicago, IL 60612 USA

[7] Univ Illinois, Dept Med, Div Endocrinol Diabet & Metab, Chicago, IL 60612 USA

来源：

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM | 2025年

基金：

美国国家卫生研究院;

关键词：

multidimensional sleep health; type; 1; diabetes; glycemic status; glycemic variability; diabetes self-management; psychological health; VARIABILITY; RECOMMENDATIONS; ADULTS;

D O I：

10.1210/clinem/dgaf032

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Context: Sleep health is multidimensional. While studies have shown associations between certain sleep dimensions and health in type 1 diabetes (T1D), global sleep health has rarely been considered. Objective: To examine the associations between individual sleep dimensions and multidimensional sleep health (MSH) on glycemic control and self-reported outcomes in T1D. Methods: Data from 116 adults with T1D participating in a sleep study (NCT04506151) were analyzed. Sleep satisfaction and alertness were assessed by questionnaires. Sleep timing, efficiency, duration, and regularity were derived from 7-day actigraphy. A composite MSH score was created by counting "healthy sleep" across these 6 measures. Glycemic control was assessed by 7-day continuous glucose monitoring and hemoglobin A1C (A1C). Self-reported outcomes were collected through questionnaires. Results: After adjusting for covariates, greater sleep irregularity was associated with higher glycemic variability (b = 5.048, P < .01), less time in range (TIR) (b = -10.806, P < .01), higher time above range (TAR) (b = 7.40, P < .05), and higher A1C (b = .365, P < .05)]. Poor sleep satisfaction was associated with higher diabetes distress and depression (b = .29, P < .05, b = 3.59, P < .05), respectively. Later sleep timing was associated with higher depression (b = 1.545, P < .05), while lower sleep efficiency was associated with higher depression (b = 1.545, P < .01). Worse MSH was significantly associated with lower TIR (b = 2.376, P < .05), higher TAR, higher A1C, and depression (b = -2.38, P < .05; b = -.177, P < .01; b = -1.275, P < .05, respectively). Conclusion: Sleep irregularity likely drives the association between MSH and glycemic control, while poor sleep satisfaction, lower efficiency, and later timing contribute to the association between MSH and depression. These results highlight the importance of comprehensive sleep health evaluation in T1D.

引用

页数：9